DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico
DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
- DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
- The Mexico City Prospective Study reflects a long-standing collaboration between Universidad Nacional Autónoma de México (UNAM) and Oxford Population Health.
- “Our work with Oxford Population Health, DNAnexus, and AWS presents a unique opportunity for researchers in Mexico to advance medical research for the people of Mexico,” said Jesús Alegre-Díaz, Professor of Epidemiology at UNAM and Principal Investigator for the Mexico City Prospective Study.
- “From this Mexico Prospective Study to the UK Biobank to Our Future Health, the DNAnexus platform continues to be the trusted platform of choice for the world’s largest biomedical research programs.